Page 6,591«..1020..6,5906,5916,5926,593..6,6006,610..»

Chiropractic Neurology: Breakthrough or Placebo?

Posted: Published on August 18th, 2012

Will Arlen has a traumatic brain injury and is so sensitive to light that he wears sunglasses all the time. The 17-year-old describes his migraines as like a knife stabbing his brain. His short term memory is shot. He can barely stand up on his own or move his left arm. The teenager from Exeter, N.H., said his symptoms developed after an illegal hit during a lacrosse game gave him a concussion so severe that it sent him into an 8-month downward spiral. His father, Larry Arlen, said his son used to be an active, outgoing, straight-A student, but they have had to pull him out of school because of his condition. Will, however, believes Ted Carrick, a chiropractor who specializes in the brain, holds the key to a miraculous cure for his condition. Carrick, who has 28 clinics worldwide and sees patients all over the world, practices a therapy he calls chiropractic neurology, a treatment he has been perfecting for 33 years. He rarely grants interviews, but allowed "Nightline" to be the first American television network to watch the treatment unfold at his clinic at Life University in Marietta, Ga. Watch the full story on "Nightline" tonight at 11:35 … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Chiropractic Neurology: Breakthrough or Placebo?

First Saskatchewan resident heads to U.S. for possible MS liberation therapy: video

Posted: Published on August 18th, 2012

SASKATOON -- A Saskatoon man is going to the U.S. to see if he can take part in a clinical trial of the so-called liberation treatment for multiple sclerosis. Andrew Dahlen is the first Saskatchewan resident to go to Albany, N.Y., for the final eligibility screening in a two-year, double-blind clinical trial. I think the possible benefit will outweigh the real risks of it. Im certainly terrified for going but Im more excited, so Im not really too concerned about the risks, Dahlen said Thursday. The province is putting up $2.2 million to have 86 Saskatchewan patients take part in the trial. All prospective participants are first screened by a neurologist to ensure they meet eligibility requirements. A successful candidate must be a Saskatchewan resident, under the age of 60 and not had liberation treatment. Candidates then spend several days at Albany Medical Centre, where a final assessment determines whether they will be accepted into the trial. The nature of the double-blind study means half of those participating will receive liberation therapy and half will get a placebo procedure. Dahlen, 28, is optimistic. In any scientific test there has to be a control group, so Im thinking even if I … Continue reading →

Posted in MS Treatment | Comments Off on First Saskatchewan resident heads to U.S. for possible MS liberation therapy: video

Stem Cell Therapy: The Hope and the Hype

Posted: Published on August 18th, 2012

By Shane Huntington Pioneering stem cell researcher Prof Martin Pera discusses where stem cell research has been and where its going, the therapeutic potential of stem cell technologies, and what we should and shouldnt expect from this fast-developing research field. With host Dr Shane Huntington. SHANE HUNTINGTON Over the last couple of decades stem cells have been touted as the key to treating a wide range of diseases, with advantages that exceed surgical repair or even organ transplantation; but work on stem cells, especially those derived from human embryos, has drawn significant public scrutiny. In many countries embryonic stem cell research is tightly regulated, and researchers have been forced to explore other research options. Such restrictions are not present worldwide and, in some countries, regulation has yet to catch up with the science. This can make it especially challenging for patients trying to navigate through the world of therapeutic stem cell technologies, both in trial phase and on the consumer market. To explore these issues and the technology itself we are joined on Up Close by one of the pioneers of stem cell research: Professor Martin Pera, program leader of Stem Cells Australia, and professor of stem cell sciences at … Continue reading →

Comments Off on Stem Cell Therapy: The Hope and the Hype

Pryor, Boozman help celebrate new UAMS cancer research labs

Posted: Published on August 18th, 2012

LITTLE ROCK, Ark. (KTHV)- U.S. Sens. Mark Pryor and John Boozman were on hand today for the unveiling of new cancer research labs at the University of Arkansas for Medical Sciences (UAMS). Located on the ninth and 11th floors of the UAMS Winthrop P. Rockefeller Cancer Institute, the space features research labs designed with an open floor plan to promote collaboration and interaction among scientists. "Research is the key to understanding why cancer develops and in finding new, more effective ways to treat our patients. These research labs will give us a significant advantage as we move forward in our current and new research programs," said Peter Emanuel, M.D., Cancer Institute director and professor of medicine the UAMS College of Medicine. The construction project, paid for by a nearly $10.5 million grant from the National Institutes of Health (NIH), completes two previously unfinished floors in the Cancer Institute's expansion tower that opened in August 2010. Funding for the grant came from the American Recovery and Reinvestment Act of 2009 stimulus monies allocated to the NIH for construction grants. "All Arkansans can be proud of the research being conducted at UAMS. This expansion, made possible in part with stimulus funds, will … Continue reading →

Comments Off on Pryor, Boozman help celebrate new UAMS cancer research labs

Stem Cell Therapy: The Hope and the Hype

Posted: Published on August 18th, 2012

By Shane Huntington Pioneering stem cell researcher Prof Martin Pera discusses where stem cell research has been and where its going, the therapeutic potential of stem cell technologies, and what we should and shouldnt expect from this fast-developing research field. With host Dr Shane Huntington. SHANE HUNTINGTON Over the last couple of decades stem cells have been touted as the key to treating a wide range of diseases, with advantages that exceed surgical repair or even organ transplantation; but work on stem cells, especially those derived from human embryos, has drawn significant public scrutiny. In many countries embryonic stem cell research is tightly regulated, and researchers have been forced to explore other research options. Such restrictions are not present worldwide and, in some countries, regulation has yet to catch up with the science. This can make it especially challenging for patients trying to navigate through the world of therapeutic stem cell technologies, both in trial phase and on the consumer market. To explore these issues and the technology itself we are joined on Up Close by one of the pioneers of stem cell research: Professor Martin Pera, program leader of Stem Cells Australia, and professor of stem cell sciences at … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Therapy: The Hope and the Hype

Family ties: Trinity woman with leukemia receives stem cells from brother

Posted: Published on August 18th, 2012

CHAPEL HILL Kathy DeClue loves her youngest brother Don Hammed for many reasons. These days, Dons selflessness is at the top of her list. Don donated the stem cells I received during my transplant, said Kathy, 57, of Trinity, in Randolph County. It was a favor I never thought Id have to ask for. But I would have done the same for him if he needed me to. Kathy needed the stem cell transplant to treat chronic lymphocytic leukemia (CLL), a cancer of the blood cells. For some CLL patients, the disease progresses slowly and they may never need treatment. For others, like Kathy, the disease was on fast-forward and required aggressive medical attention. From the start, we knew that the CLL was behaving like a high-risk disease and was resistant to just about all the therapies we have, said James M. Coghill, MD, assistant professor of hematology and oncology at the UNC School of Medicine, a member of UNC Lineberger Comprehensive Cancer Center and the leader of Kathys health care team. The stem cell transplant on April 25 was the best option for trying to get her disease under control, and Kathy had the luxury of three siblings who … Continue reading →

Comments Off on Family ties: Trinity woman with leukemia receives stem cells from brother

Stem Cell Therapy: The Hope and the Hype

Posted: Published on August 18th, 2012

By Shane Huntington Pioneering stem cell researcher Prof Martin Pera discusses where stem cell research has been and where its going, the therapeutic potential of stem cell technologies, and what we should and shouldnt expect from this fast-developing research field. With host Dr Shane Huntington. SHANE HUNTINGTON Over the last couple of decades stem cells have been touted as the key to treating a wide range of diseases, with advantages that exceed surgical repair or even organ transplantation; but work on stem cells, especially those derived from human embryos, has drawn significant public scrutiny. In many countries embryonic stem cell research is tightly regulated, and researchers have been forced to explore other research options. Such restrictions are not present worldwide and, in some countries, regulation has yet to catch up with the science. This can make it especially challenging for patients trying to navigate through the world of therapeutic stem cell technologies, both in trial phase and on the consumer market. To explore these issues and the technology itself we are joined on Up Close by one of the pioneers of stem cell research: Professor Martin Pera, program leader of Stem Cells Australia, and professor of stem cell sciences at … Continue reading →

Comments Off on Stem Cell Therapy: The Hope and the Hype

Scouts monitoring Mathieu situation

Posted: Published on August 18th, 2012

For Tyrann Mathieu, the best way to get back onto the football field -- and stay there -- appears to be taking a season off. That's the plan according to his father, Tyrone Mathieu, who Jen Hale of Fox 8 Sports in New Orleans, spoke to Thursday night. According to Hale's report, the "Honey Badger" has been at a drug and alcohol recovery center in Houston since Monday and will not pursue playing football until he successfully graduates from the program. CBS columnist Bruce Feldman confirmed the report, adding that Mathieu is specifically there to treat marijuana issues. Gannett News Services reported Mathiieu would have had to fail at least four drug tests to be dismissed from the team. Mathieu is also reportedly meeting daily with former NBA star and head coach John Lucas, who struggled with his own addictions during his playing career and has since become one of the more highly regarded "life coaches" for athletes battling drug and alcohol dependency. While there has been plenty of interest from teams looking to add Mathieu since his abrupt suspension by LSU -- the university was contacted by more than a dozen teams -- time was running out for the … Continue reading →

Posted in Drug Dependency | Comments Off on Scouts monitoring Mathieu situation

Optum Announces Job Growth in California

Posted: Published on August 18th, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)-- OptumRx, a leading pharmacy benefits management (PBM) organization and one of the Optum companies of UnitedHealth Group (UNH), will create 600 new jobs in California by the end of 2013, including 250 at the new pharmacy order processing facility in Mission Valley to handle mail order prescription processing. The new jobs are in addition to 400 new jobs OptumRx already has created and filled in California in 2012. The announcement was made at a news conference today, attended by California Lt. Gov. Gavin Newsom, Congressman Darrell Issa and Dirk McMahon, CEO of OptumRx, at the companys existing mail service pharmacy in Carlsbad. This year, UnitedHealth Group has announced more than 1,000 new jobs for the state, including 115 new jobs announced last month for the operations center in Chico, California, with the remainder split between Orange and San Diego counties and all expected to be filled by the end of next year. I am pleased that Optum and UnitedHealth Group recognize the many benefits of growing a business in California, from the high-quality workforce to our excellent business climate, said Lt. Gov. Newsom. The hundreds of jobs Optum will create here over the coming months show that … Continue reading →

Posted in Pharmacy | Comments Off on Optum Announces Job Growth in California

Protecting prion protein keeps stem cells young

Posted: Published on August 17th, 2012

COULD we stem the tide of ageing by delaying the deterioration of stem cells? A new compound that appears to do just that could help us find ways to protect our organs from age-related wear and tear, experiments in mice suggest. As we age, so do our mesenchymal stem cells (MSCs): their numbers in our bone marrow decline, and those that are left lose the ability to differentiate into the distinct cell types - such as bone, cartilage, fat and possibly muscle cells - that help in the healing process. "We think this ageing of stem cells may be linked to the onset of some age-related disorders, such as osteoporosis," says Ilaria Bellantuono at the University of Sheffield in the UK. Earlier research in mice had suggested that the prion protein expressed by MSCs might play a role in holding back stem cell ageing. Mice lacking the prion protein were less able to regenerate blood cells. The study provided more evidence that correctly folded prions serve a useful purpose in the body, despite the role that misfolded prions play in BSE and vCJD. Bellantuono and her colleagues have now found that the prion protein performs a similar function in humans … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Protecting prion protein keeps stem cells young

Page 6,591«..1020..6,5906,5916,5926,593..6,6006,610..»